Belite Bio Inc ADR
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -9,740 | -10,436 | -6,955 | |
EBIT | -10,471 | -6,989 | ||
Net Income | -8,679 | -9,494 | -9,494 | -6,991 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cash | 95,500 | 88,157 | ||
Basic Shares | 30,687 | 30,612 | 30,324 | 28,316 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -399 | -198 | -30 | -17 |
EBITDA | -31,529 | -12,434 | -9,636 | -5,714 |
EBIT | -31,668 | -12,632 | -9,666 | -5,731 |
Net Income | -31,632 | -12,475 | -9,792 | -5,753 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,900 | -11,852 | -7,548 | -4,462 |
Cash | 88,157 | 42,089 | 17,344 | 25,618 |
Basic Shares | 26,593 | 19,976 | 24,095 | 24,095 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.28 |
2024-06-30 | -$0.31 |
2024-03-31 | -$0.27 |
2023-12-31 | -$0.25 |
